Filing Details
- Accession Number:
- 0001062993-23-017283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-30 16:09:27
- Reporting Period:
- 2023-08-28
- Accepted Time:
- 2023-08-30 16:09:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1811623 | Paxmedica Inc. | PXMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1822915 | Karen Larochelle | C/O Paxmedica, Inc. 303 South Broadway, Suite 125 Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-28 | 2,000 | $0.50 | 52,129 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-29 | 456 | $0.48 | 51,673 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
- The sale price represents the weighted average sale price of the shares sold ranging from $0.5005 to $0.5202 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The sale price represents the weighted average sale price of the shares sold ranging from $0.4844 to $0.4899 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
